Bonesupport Holding AB (BONEX) - Total Assets
Based on the latest financial reports, Bonesupport Holding AB (BONEX) holds total assets worth Skr1.01 Billion SEK (≈ $108.17 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bonesupport Holding AB - Total Assets Trend (2014–2024)
This chart illustrates how Bonesupport Holding AB's total assets have evolved over time, based on quarterly financial data. Also see Bonesupport Holding AB stock valuation for the company's overall valuation and market capitalisation.
Bonesupport Holding AB - Asset Composition Analysis
Current Asset Composition (December 2024)
Bonesupport Holding AB's total assets of Skr1.01 Billion consist of 70.8% current assets and 29.2% non-current assets. Review BONEX current and long-term liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr227.00 Million | 25.8% |
| Accounts Receivable | Skr240.73 Million | 27.4% |
| Inventory | Skr134.11 Million | 15.3% |
| Property, Plant & Equipment | Skr20.68 Million | 2.4% |
| Intangible Assets | Skr14.54 Million | 1.7% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Bonesupport Holding AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Bonesupport Holding AB stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bonesupport Holding AB's current assets represent 70.8% of total assets in 2024, a decrease from 87.4% in 2014.
- Cash Position: Cash and equivalents constituted 25.8% of total assets in 2024, down from 40.3% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 11.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 27.4% of total assets.
Bonesupport Holding AB Competitors by Total Assets
Key competitors of Bonesupport Holding AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
Bonesupport Holding AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.73 | 4.74 | 7.31 |
| Quick Ratio | 3.92 | 3.50 | 6.56 |
| Cash Ratio | 2.34 | 0.00 | 0.00 |
| Working Capital | Skr605.93 Million | Skr404.00 Million | Skr381.01 Million |
Bonesupport Holding AB - Advanced Valuation Insights
This section examines the relationship between Bonesupport Holding AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 13.89 |
| Latest Market Cap to Assets Ratio | 1.75 |
| Asset Growth Rate (YoY) | 27.7% |
| Total Assets | Skr879.69 Million |
| Market Capitalization | $1.54 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Bonesupport Holding AB's assets above their book value (1.75x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Bonesupport Holding AB's assets grew by 27.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Bonesupport Holding AB (2014–2024)
The table below shows the annual total assets of Bonesupport Holding AB from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr879.69 Million ≈ $94.67 Million |
+27.71% |
| 2023-12-31 | Skr688.82 Million ≈ $74.13 Million |
+85.26% |
| 2022-12-31 | Skr371.82 Million ≈ $40.01 Million |
+8.11% |
| 2021-12-31 | Skr343.92 Million ≈ $37.01 Million |
-26.07% |
| 2020-12-31 | Skr465.22 Million ≈ $50.06 Million |
+136.95% |
| 2019-12-31 | Skr196.33 Million ≈ $21.13 Million |
-39.80% |
| 2018-12-31 | Skr326.14 Million ≈ $35.10 Million |
-45.34% |
| 2017-12-31 | Skr596.68 Million ≈ $64.21 Million |
+216.03% |
| 2016-12-31 | Skr188.81 Million ≈ $20.32 Million |
+69.13% |
| 2015-12-31 | Skr111.63 Million ≈ $12.01 Million |
+144.70% |
| 2014-12-31 | Skr45.62 Million ≈ $4.91 Million |
-- |
About Bonesupport Holding AB
Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin duri… Read more